Paclitaxel-Loaded Poly(n-butylcyanoacrylate) Nanoparticle Delivery System to Overcome Multidrug Resistance in Ovarian Cancer

RETRACTED: Thymoquinone poly (lactide-co-glycolide) nanoparticles exhibit enhanced anti-proliferative, anti-inflammatory, and chemosensitization potential

(2010) Jayaraj Ravindran et al.   BIOCHEMICAL PHARMACOLOGY

A novel paclitaxel-loaded poly(ε-caprolactone)/Poloxamer 188 blend nanoparticle overcoming multidrug resistance for cancer treatment

(2009) Yangqing Zhang et al.   Acta Biomaterialia

Doxorubicin loaded Polymeric Nanoparticulate Delivery System to overcome drug resistance in osteosarcoma

(2009) Michiro Susa et al.   BMC CANCER

Doxorubicin and Paclitaxel-Loaded Lipid-Based Nanoparticles Overcome Multidrug Resistance by Inhibiting P-Glycoprotein and Depleting ATP

(2009) X. Dong et al.   CANCER RESEARCH

Hyaluronic acid coated poly(butyl cyanoacrylate) nanoparticles as anticancer drug carriers

(2009) Miao He et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Encapsulation of Water-Insoluble Drugs in Poly(butyl cyanoacrylate) Nanoparticles

(2009) Telli Hekmatara et al.   JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY

Nanomicellar paclitaxel increases cytotoxicity of multidrug resistant breast cancer cells

(2008) Hayat Önyüksel et al.   CANCER LETTERS